Is prehypertension really different from normotension and hypertension a case-control pilot proteomic study in chinese

Clinical and Experimental Hypertension

Volumn 31, Issue 4, 2009, Pages 316-329

  Wang, Zuoguang ^a   Peng, Xiaoyun ^b   Tao, Yanduo ^b   Liu, Ya ^a   Liu, Jieling ^a   Chen, Xingjun ^a   Wen, Shaojun ^a   Wu, Zhaosu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NORTHWEST INSTITUTE OF PLATEAU BIOLOGY   (China)

Author keywords

Hypertension; Pathogenesis; Plasma; Prehypertension; Proteomics

Indexed keywords

ANTIOXIDANT; PLASMA PROTEIN; PROTEOME;

ADULT; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; CELL PROLIFERATION; CHINESE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HYPERTENSION; IMMUNITY; INFLAMMATION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PREHYPERTENSION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL ELECTROPHORESIS;

ADULT; APOPTOSIS; BLOOD PRESSURE; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHINA; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FIBRINOLYSIS; HUMANS; HYPERTENSION; IMMUNITY; INFLAMMATION; LIPID METABOLISM; MALE; MIDDLE AGED; PILOT PROJECTS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 70849085724     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960902977890     Document Type: Article

References (43)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005; 365:217-223.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seven report of joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42:1206-1252. (Pubitemid 37553153)
3. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the New National Committee Guidelines. Arch Intern Med 2004; 164:2126-2134.
4. Bolli P, Hemmelgarn B, Myers MG, McKay D, Tremblay G, Tobe SW. High normal blood pressure and prehypertension: The debate continues. Can J Cardiol 2007; 23:581-583.
5. Izzo JL Jr. Prehypertension: Demographics, pathophysiology, and treatment. Curr Hypertens Rep 2007; 9:264-268.
6. Anderson NL, Anderson NG. The human plasma proteome. Mol Cell Proteomics 2002; 1:845-867.
7. Shankar A, Li J. Association between serum gamma-glutamyltransferase level and prehypertension among US adults. Circ J 2007; 71:1567-1572. (Pubitemid 47529658)
8. Papadopoulos DP, Makris TK, Krespi PG, Poulakou M, Stavroulakis G, Hatzizacharias AN, Perrea D, Votteas VV. Adiponectin and resistin plasma levels in healthy individuals with prehypertension. J Clin Hypertens (Greenwich) 2005; 7:729-733.
9. Jin X, Xia L, Wang LS, Shi JZ, Zheng Y, Chen WL, Zhang L, Liu ZG, Chen GQ, Fang NY. Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. Proteomics 2006; 6:1948-1956.
10. Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47:962-967.
11. Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, Dunn MJ. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000; 21:3666-3672.
12. Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, Kohsaka S. Plasminogen binds specifically to a-enolase on rat neuronal plasma membrane. J Neurochem 1994; 63:2048-2057.
13. FCloix, MA Devynck, JL Brentano, P Meyer. Plasma protein changes in primary hypertension in humans and rats. Hypertension 1983; 5:128-134.
14. Shen B, El-Dahr SS. Cross-talk of the renin-angiotensin and kallikrein-kinin systems. Biol Chem 2006; 387:145-150.
15. Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens 2006; 15:152-158.
16. Sonmez A, Dogru T, Yilmaz MI, Ocal R, Ozgurtas T, Kilic S, Eyileten T, Tasci I, Erbil K, Kocar IH.Soluble CD40 ligand levels in patients with hypertension. Clin Exp Hypertens 2005; 27:629-634.
17. Madej A, Okopien B, Kowalski J, Haberka M, Herman ZS. Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension. Pharmacol Rep 2005; 57:878-881.
18. Manabe S, Okura T, Watanabe S, Fukuoka T, Higaki J. Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension. J Cardiovasc Pharmacol 2005; 46:735-739.
19. Das UN. Hypertension as a low-grade systemic inflammatory condition that has its origins in the perinatal period. J Assoc Physicians India 2006; 54:133-142.
20. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: Molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 2007; 112:375-384.
21. King DE, Egan BM, Mainous AG, Geesey ME. Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich) 2004; 6:562-568.
22. Carter K, Worwood M. Haptoglobin: A review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 2007; 29:92-110.
23. Garfagnini A, Devoto G, Rosselli P, Boggiano P, Venturini M. Relationship between HDLcholesterol and apolipoprotein A1 and the severity of coronary artery disease. Eur Heart J 1995; 16:465-470.
24. Carriere V, Vidal R, Lazou K, Lacasa M, Delers F, Ribeiro A, Rousset M, Chambaz J, Lacorte JM. HNF-4-dependent induction of apolipoprotein A-IV gene 2 transcription by an apical supply of lipid micelles in intestinal cells. J Biol Chem 2005; 280:5406-5413.
25. Trougakos IP, Lourda M, Agiostratidou G, Kletsas D, Gonos ES. Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic Biol Med 2005; 38:436-449.
26. Naya M, Tsukamoto T, Morita K, Katoh C, Furumoto T, Fujii S, Tamaki N, Tsutsui H. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients. Hypertens Res 2007; 30:541-548. http://www.ncbi.nlm.nih.gov.
27. Steinberg D. Hypercholesterolemia and inflammation in atherogenesis: Two sides of the same coin. Mol Nutr Food Res 2005; 49:995-998.
28. Piro M, Giubilato G, Pinnelli M, Giordano Sciacca P, Biasucci LM. Endothelium and inflammation. Panminerva Med 2005; 47:75-80.
29. Vidt DG. Angiotensin-receptor blockers for prehypertension. Curr Hypertens Rep 2006; 8:361-362.
30. Nesbitt SD. Perspectives on prehypertension. J Cardiometab Syndr 2006; 1:364-365.
31. Julius S, Nesbitt SD, Egan BM, Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354:1685-1697.
32. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 2007; 35:849-855.
33. Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 2005; 579:41-47.
34. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int 2005; 67:2383-2392.
35. Jones AL, Hulett MD, Parish CR. Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol 2005; 83:106-118.
36. Erdogan D, Caliskan M, Yildirim I, Gullu H, Baycan S, Ciftci O, Yildirir A, Muderrisoglu H. Effects of normal blood pressure, prehypertension and hypertension on left ventricular diastolic function and aortic elastic properties. Blood Press 2007; 16:114-121. (Pubitemid 47050373)
37. Ninomiya T, Kubo M, Doi Y, Yonemoto K, Tanizaki Y, Tsuruya K, Sueishi K, Tsuneyoshi M, Iida M, Kiyohara Y. Prehypertension increases the risk for renal arteriosclerosis in autopsies: The Hisayama Study. J Am Soc Nephrol 2007; 18:2135-2142.
38. Irene G, Haralambos G. Hypertension, vasoactive peptides and coagulation factors. J Hypertens 2004; 22:1091-1092.
39. Armas-Hernández MJ, Hernández-Hernández R, Armas-Padilla MC, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero-Pajuelo J, Israili ZH, Valasco M. Fibrinolytic system in normotensive subjects and hypertensive patients. Am J Ther 2007; 14:177-182.
40. Kakar P, Lip GY. Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy. Expert Rev Cardiovasc Ther 2007; 5:441-450.
41. Barath A, Nemeth I, Karg E, Endreffy E, Bereczki C, Gellén B, Haszon I, Túri S. Roles of paraoxonase and oxidative stress in adolescents with uremia, essential or obesity-induced hypertension. Kidney Blood Press Res 2006; 29:144-151.
42. Tandon R, Sinha MK, Garg H, Khanna R, Khanna HD. Oxidative stress in patients with essential hypertension. Natl Med J India 2005; 18:297-299.
43. Vari IS, Balkau B, Kettaneh A, André P, Tichet J, Fumeron F, Caces E, Marre M, Grandchamp B, Ducimetière P. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007;30:1795-1801.